EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
FRA:ESF0 - Deutsche Boerse Ag - FR0014000MR3 - Common Stock - Currency: EUR
Taking everything into account, ESF0 scores 6 out of 10 in our fundamental rating. ESF0 was compared to 18 industry peers in the Life Sciences Tools & Services industry. ESF0 has an excellent profitability rating, but there are some minor concerns on its financial health. ESF0 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ESF0 was profitable.
In the past year ESF0 had a positive cash flow from operations.
Each year in the past 5 years ESF0 has been profitable.
ESF0 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 3.24%, ESF0 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Equity value of 6.61%, ESF0 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.18%, ESF0 is doing good in the industry, outperforming 77.78% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 6.84%.
The last Return On Invested Capital (9.18%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.24% | ||
| ROE | 6.61% | ||
| ROIC | 9.18% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ESF0 has a Profit Margin of 5.08%. This is comparable to the rest of the industry: ESF0 outperforms 50.00% of its industry peers.
In the last couple of years the Profit Margin of ESF0 has grown nicely.
ESF0 has a Operating Margin of 14.97%. This is in the better half of the industry: ESF0 outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
ESF0 has a worse Gross Margin (22.33%) than 83.33% of its industry peers.
ESF0's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.97% | ||
| PM (TTM) | 5.08% | ||
| GM | 22.33% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
ESF0 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ESF0 has less shares outstanding
The number of shares outstanding for ESF0 has been increased compared to 5 years ago.
Compared to 1 year ago, ESF0 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.75 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.75, ESF0 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
The Debt to FCF ratio of ESF0 is 4.57, which is a neutral value as it means it would take ESF0, 4.57 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.57, ESF0 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that ESF0 is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, ESF0 is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 4.57 | ||
| Altman-Z | 2.75 |
ROIC/WACC1.25
WACC7.33%
2.3 Liquidity
A Current Ratio of 1.16 indicates that ESF0 should not have too much problems paying its short term obligations.
ESF0 has a Current ratio of 1.16. This is amonst the worse of the industry: ESF0 underperforms 83.33% of its industry peers.
A Quick Ratio of 1.09 indicates that ESF0 should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.09, ESF0 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.63%, which is quite impressive.
Measured over the past years, ESF0 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
The Revenue has been growing slightly by 6.70% in the past year.
The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
3.2 Future
The Earnings Per Share is expected to grow by 13.47% on average over the next years. This is quite good.
ESF0 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.47% yearly.
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y13.47%
Revenue Next Year6.31%
Revenue Next 2Y6.36%
Revenue Next 3Y6.54%
Revenue Next 5Y6.47%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.80, the valuation of ESF0 can be described as expensive.
ESF0's Price/Earnings ratio is in line with the industry average.
ESF0 is valuated rather expensively when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
ESF0 is valuated rather expensively with a Price/Forward Earnings ratio of 17.08.
ESF0's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ESF0 is cheaper than 77.78% of the companies in the same industry.
ESF0 is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.8 | ||
| Fwd PE | 17.08 |
4.2 Price Multiples
ESF0's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ESF0 is cheaper than 88.89% of the companies in the same industry.
ESF0's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ESF0 is cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.02 | ||
| EV/EBITDA | 8.16 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ESF0 does not grow enough to justify the current Price/Earnings ratio.
ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ESF0's earnings are expected to grow with 14.00% in the coming years.
PEG (NY)2.21
PEG (5Y)1.84
EPS Next 2Y14.58%
EPS Next 3Y14%
5. Dividend
5.1 Amount
ESF0 has a yearly dividend return of 0.99%, which is pretty low.
ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.72. ESF0 pays more dividend than 88.89% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, ESF0's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
5.2 History
On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ESF0 pays out 27.77% of its income as dividend. This is a sustainable payout ratio.
The dividend of ESF0 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.77%
EPS Next 2Y14.58%
EPS Next 3Y14%
FRA:ESF0 (7/18/2025, 7:00:00 PM)
60.84
-0.3 (-0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.08B
Analysts68.89
Price Target61.93 (1.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP27.77%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)3.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.8 | ||
| Fwd PE | 17.08 | ||
| P/S | 1.59 | ||
| P/FCF | 14.02 | ||
| P/OCF | 8.4 | ||
| P/B | 2.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.16 |
EPS(TTM)1.8
EY2.96%
EPS(NY)3.56
Fwd EY5.85%
FCF(TTM)4.34
FCFY7.13%
OCF(TTM)7.24
OCFY11.9%
SpS38.16
BVpS29.31
TBVpS-1.59
PEG (NY)2.21
PEG (5Y)1.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.24% | ||
| ROE | 6.61% | ||
| ROCE | 11.86% | ||
| ROIC | 9.18% | ||
| ROICexc | 9.87% | ||
| ROICexgc | 31.79% | ||
| OM | 14.97% | ||
| PM (TTM) | 5.08% | ||
| GM | 22.33% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score8
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 4.57 | ||
| Debt/EBITDA | 1.81 | ||
| Cap/Depr | 76.4% | ||
| Cap/Sales | 7.6% | ||
| Interest Coverage | 9.11 | ||
| Cash Conversion | 76.13% | ||
| Profit Quality | 224% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 2.75 |
F-Score8
WACC7.33%
ROIC/WACC1.25
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y13.47%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
Revenue Next Year6.31%
Revenue Next 2Y6.36%
Revenue Next 3Y6.54%
Revenue Next 5Y6.47%
EBIT growth 1Y23.67%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year87.7%
EBIT Next 3Y30.85%
EBIT Next 5Y22.29%
FCF growth 1Y68.95%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y29.56%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%